Skip to main content
. 2003 May;23(9):3079–3090. doi: 10.1128/MCB.23.9.3079-3090.2003

FIG. 6.

FIG. 6.

Effects of Mxi2 on ERK phosphorylation and activation levels. (A) Effects of Mxi2 on the activation of ERK2 by MEK. 293T cells were transfected with HA-ERK2 cotransfected with vector or with MEK1E (1 μg) in the presence (+) or absence (−) of Mxi2 (1 μg). Phosphorylated MBP (p-MBP) levels indicate ERK activity levels. (Bottom) Expression levels of MEK and Mxi2. (B) Effect of Mxi2 on ERK2 basal activity levels. Cells were transfected with HA-ERK2 (1 μg) in the presence (+) or absence (−) of Mxi2 (1 μg). After 18 h of starvation, ERK kinase activity was determined as described previously. Phospho-MBP levels became apparent after prolonged exposure at −70°C. (Bottom) Expression levels of HA-ERK2 and Mxi2. (C) Effects of Mxi2 on EGF-induced phosphorylation of ERK2. Cells transfected with HA-ERK2 (1 μg) and increasing amounts of Mxi2 (2 and 5 μg) were stimulated with EGF for 5 min and probed for phospho-ERK in anti-HA immunoprecipitates. (Bottom) Levels of immunoprecipitated HA-ERK2. (D) Effects of Mxi2 on the dephosphorylation rate of ERK2. Cells were transfected with (+) or without (−) AU5-Mxi2 and stimulated with EGF (100 ng/ml), and phospho-ERK levels in total lysates were examined at the indicated times. (Bottom) Expression of ERK1/2 and AU5-Mxi2. (E) Effects of Mxi2 dead kinase (DK) on ERK2 dephosphorylation. Cells transfected with the indicated constructs were stimulated with EGF, and phospho-ERK levels were determined after 2 and 5 h. (Bottom) Expression of p38 proteins detected by immunoblotting with anti-p38 N terminus antibody. WB, Western blot; c, control.

HHS Vulnerability Disclosure